New Zealand Health Minister Denies Connection to Tobacco Industry

Sep.27.2024
New Zealand Health Minister Denies Connection to Tobacco Industry
New Zealand Health Minister Casey Costello strongly denies any ties to tobacco industry at health alliance meeting.

According to a report by MSN on September 27th, New Zealand's Deputy Health Minister Casey Costello strongly denied any connections with the tobacco industry at a health alliance meeting on Tuesday.


According to reports, at the meeting, Costello came under scrutiny from health researchers for loosening anti-smoking laws and providing a document titled "Nicotine is just as harmful as caffeine." The document also criticized the Labour Party's Smoke-Free Generation policy as being "nanny-state nonsense".


The minister recently reduced the consumption tax on heated tobacco products (HTP), making them a more attractive alternative to smoking. These changes align with the demands of tobacco companies, with the main player in the heated tobacco products market being Philip Morris International, which employs two former senior officials of the New Zealand First Party.


I have never had any association with the tobacco industry," Costello said in response to questioning of his credibility at the conference. "Despite extensive efforts, including the Freedom of Information Act and written parliamentary inquiries, no evidence has been found linking me to the tobacco industry, and I have never sought advice from them.


Costello added that according to documents obtained by the New Zealand Broadcasting Corporation under the Official Information Act, there is nothing in conflict with the policy positions of the New Zealand First Party.


Costello stated that the government is committed to achieving the Smoke-Free 2025 goal, which will require approximately 80,000 people to quit smoking by the end of next year to reach this target.


Due to the availability of alternatives such as e-cigarettes, many people have quit smoking. She also mentioned that legislation is being introduced to make smoking alternatives more affordable.


We need a set of appropriate legislation and regulatory systems to provide equal levels of regulation for smoking and other nicotine products.


She emphasized that the Smokefree 2025 goal is just the beginning. "We still need to remain vigilant to ensure that New Zealand remains smokefree, young people do not start smoking or using e-cigarettes, and those who have quit smoking or quit using e-cigarettes do not start again.


Chris Bullen, a tobacco researcher at the University of Auckland, is skeptical about New Zealand's ability to achieve its Smokefree 2025 goal. "I don't believe that the current plan will allow us to reach this goal, and it definitely cannot be achieved without significant costs," he said.


He also stated that repealing the smoke-free legislation is harmful, and believes that introducing new nicotine products into the market without testing is a radical experiment. However, he supports the government's efforts to improve regulation of smoking alternatives.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s new tobacco and nicotine framework marks a shift from prohibition toward registration, traceability and health surveillance. Argentine THR advocate Juan Facundo Teme told 2Firsts that adult consumers and parts of the local commercial sector are cautiously optimistic, but concerns remain over flavor limits, registration costs and market access. The policy’s implementation may determine whether Argentina can move informal sales into regulated channels.
May.11
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
PMI’s Smoke-Free Business Accounts for 43% of Net Revenues in Q1 as Full-Year EPS Guidance Rises
On April 22, 2026, Philip Morris International released its first-quarter 2026 results. The report showed net revenues of $10.146 billion, up 9.1% year on year; adjusted diluted EPS of $1.96, up 16.0%; and smoke-free products accounting for 43% of total net revenues. Based on first-quarter performance, the company raised its 2026 full-year adjusted diluted EPS forecast to $8.36 to $8.51, or $8.11 to $8.26 excluding currency.
Apr.23 by 2FIRSTS.ai
UK Vaping Products Duty to Raise £565 Million by 2030/31
UK Vaping Products Duty to Raise £565 Million by 2030/31
The UK will introduce Vaping Products Duty on all vaping liquids from October 1, 2026, with government revenue forecast to rise from £135 million in 2026/27 to £565 million by 2030/31.
Jun.18
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts held a U.S. compliance briefing in Shenzhen to help vaping, heated tobacco and nicotine pouch supply chain companies strengthen PMTA support capabilities. The event focused on supplier documentation, quality systems, traceability, TPMF/TPMP pathways, age verification and customer audit readiness as U.S. compliance expectations increasingly extend deeper into the nicotine supply chain.
Events
Jun.12
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
RLX Technology’s Q1 net revenues rose 96.2% year over year, with international business accounting for 72.3% of total revenue. Beyond the headline growth, the results point to deeper globalization: European operations, Nexus supply-chain integration and a broader product portfolio are becoming key signals to watch.
Special Report
May.20